EUVIMEDEUVIMED entdecken
Crossref

High‐depth next‐generation sequencing panel testing in the evaluation of arteriovenous malformations

Patricia V Hernandez iD, Katherine A King, Michael J Evenson, Meagan M Corliss, Molly C Schroeder iD, Jonathan W Heusel, Julie A Neidich, Yang Cao iD

American Journal of Medical Genetics Part A · 2023

DOI: 10.1002/ajmg.a.63171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2023. Verfasst von Patricia V Hernandez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA. Hauptthemen laut MEDLINE: Arteriovenous Malformations. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arteriovenous malformations (AVMs) are vascular lesions in which an overgrowth of blood vessels of varying sizes develops with one or more direct connections between the arterial and venous circulation. We performed a retrospective review of a cohort of 54 patients with AVMs referred to our clinical genomic laboratory for high‐depth next‐generation sequencing (NGS) panel of Disorders of Somatic Mosaicism (DoSM). Thirty‐seven of 54 patients were female (68.5%). Among the 54 cases, 37 (68.5%) cases had pathogenic and/or likely pathogenic (P/LP) variants identified, two cases (3.7%) had variants of uncertain clinical significance, and the remaining 15 cases (27.8%) had negative results. MAP2K1 variants were found in 12 cases, followed by eight cases with KRAS variants and seven with TEK variants, and the remainder being identified in several other genes on the panel. Among the 37 positive cases, 32 cases had somatic alterations only; the remaining five cases had at least one germline P/LP variant, including four cases with PTEN and one with RASA1 . Of note, two cases had the unexpected co‐existence of two P/LP variants. In summary, this study illustrated the molecular diagnostic yield (68.5%) of this cohort of patients with a clinical indication of AVMs by our high‐depth DoSM NGS panel.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arteriovenous MalformationsHumansFemaleMaleMutationGerm-Line MutationChromosome AberrationsHigh-Throughput Nucleotide Sequencingp120 GTPase Activating Protein

Stichwörter der Autor:innen

arteriovenous malformationsnext-generation sequencingsomatic mosaicism

Substanzen

RASA1 protein, humanp120 GTPase Activating Protein

Autor:innen und Institutionen

  • Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.
  • Department of Pediatrics, Division of Genetics and Genomic Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.
  • Department of Genetics, Washington University School of Medicine, Saint Louis, Missouri, USA.
  • Department of Pediatrics, Washington University School of Medicine, Saint Louis, Missouri, USA.

ORCID-Profile: Patricia V Hernandez, Molly C Schroeder, Yang Cao

Zitieren

APA

Hernandez, P. V., King, K. A., Evenson, M. J., Corliss, M. M., Schroeder, M. C., Heusel, J. W., Neidich, J. A., & Cao, Y. (2023). High‐depth next‐generation sequencing panel testing in the evaluation of arteriovenous malformations. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63171

Vancouver

Hernandez PV, King KA, Evenson MJ, Corliss MM, Schroeder MC, Heusel JW, et al. High‐depth next‐generation sequencing panel testing in the evaluation of arteriovenous malformations. American Journal of Medical Genetics Part A. 2023. doi:10.1002/ajmg.a.63171

BibTeX
@article{Hernandez2023,
  author = {Hernandez, Patricia V and King, Katherine A and Evenson, Michael J and Corliss, Meagan M and Schroeder, Molly C and Heusel, Jonathan W and Neidich, Julie A and Cao, Yang},
  title = {High‐depth next‐generation sequencing panel testing in the evaluation of arteriovenous malformations},
  journal = {American Journal of Medical Genetics Part A},
  year = {2023},
  doi = {10.1002/ajmg.a.63171}
}
Kostenlos starten →